4-Bromotoluene

We are 4-Bromotoluene CAS:106-38-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:  4-Bromotoluene
CAS.NO:106-38-7
Synonyms:   4-Bromotoluene
p-Bromotoluene
Benzene, 1-bromo-4-methyl-
1-bromo-4-methylbenzene
 
Molecular Formula:C7H7Br
Molecular Weight:171.03400
 
Physical and Chemical Properties:
Density:1.39 g/mL at 25 °C(lit.)
Boiling point:184 °C(lit.)
Melting point:26-29 °C(lit.)
Flash point:185 °F
Index of Refraction:1.549
 
Specification:
Appearance:Colorless or light yellow liquid
Purity:≥99.0%
 
Packing:25kg/drum, can also be packaged according to customer requirements
Storage:The warehouse is ventilated and dried at low temperature, and stored and transported separately from oxidants and food materials.
Application:4-Bromotoluene is used as a reagent in the preparation of aromatic diselenides which are useful for generating anticancer lead compounds.

4-Bromotoluene


Related News: GlaxoSmithKline’s HIV drugs division ViiV Healthcare said on Saturday that the U.S. Food and Drug Administration declined to approve its long acting HIV injection.1,5-Naphthalene diisocyanate CAS:3173-72-6 GlaxoSmithKline’s HIV drugs division ViiV Healthcare said on Saturday that the U.S. Food and Drug Administration declined to approve its long acting HIV injection.5-formil-2,4-dimetil-1H-pirrol-3-carboxilato de etilo CAS:2199-59-9 Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).366821-62-7 Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).

Related Products
Product Name
Diethyl ethoxymethylenemalonate View Details
4-fluorobenzoic acid View Details
2-Bromo-4′-chloroacetophenone View Details
(Z)-2-(2-((tert-Butoxycarbonyl)amino)thiazol-4-yl)pent-2-enoic acid manufacturer 1-Methyl-aminomethyl naphthalene manufacturer 3,4-Difluorotoluene manufacturer 2-Chloro-6-(trifluoromethyl)pyridine manufacturer 4-tert-Butylphenyl isothiocyanate manufacturer